#anal cancer

Human papillomavirus and hepatitis B vaccines lower the risk of developing cancer.

Human papillomavirus, a common sexually transmitted infection, can cause cervical, anal, and oral cancers.

Vaccines could potentially eliminate cervical, anal, oral and other cancers caused by human papillomavirus.

Prompt detection treatment of precancerous lesions cut the likelihood of developing anal cancer by more than half.

Certain types of human papillomavirus cause almost all cases of cervical cancer.

A pilot program is assessing whether self-testing for the cancer-causing virus can reach women who otherwise might not get screened.

Prompt treatment of precancerous lesions in people with HIV reduced the likelihood of developing anal cancer by 57%.

A look back at some of the most important science and treatment news Cancer Health covered this year.

Early vaccination reduces the risk of cervical cancer by nearly 90%, but many young people remain unprotected.

Long-awaited results from the ANCHOR study suggest screening to detect precancerous lesions should be part of routine care.

A majority people with oral and throat cancer tested positive for DNA from high-risk HPV types in their saliva.

Teens can receive the cancer-preventing HPV vaccine at the same time as their COVID-19 vaccine.

The National Comprehensive Cancer Network publishes a new guide that includes updated patient guidelines for colon and rectal cancers.

The early cancer is detected, the easier it is to treat.

However, other malignancies caused by human papillomavirus, including anal and oral cancers, are on the rise.